Stanczyk FZ - Search Results

1

Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.

Wu AH, Whittemore AS, Kolonel LN, Stanczyk FZ, John EM, Gallagher RP, West DW. Wu AH, et al. Among authors: stanczyk fz. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):533-8. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352865

2

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, Henderson BE. Ross RK, et al. Among authors: stanczyk fz. Lancet. 1992 Apr 11;339(8798):887-9. doi: 10.1016/0140-6736(92)90927-u. Lancet. 1992. PMID: 1348296

3

Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.

Miles RA, Cassidenti DL, Carmina E, Gentzschein E, Stanczyk FZ, Lobo RA. Miles RA, et al. Among authors: stanczyk fz. Fertil Steril. 1992 Oct;58(4):708-12. doi: 10.1016/s0015-0282(16)55316-3. Fertil Steril. 1992. PMID: 1426314 Free article.

4

Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.

Duffy DM, Legro RS, Chang L, Stanczyk FZ, Lobo RA. Duffy DM, et al. Among authors: stanczyk fz. Fertil Steril. 1995 Oct;64(4):736-9. doi: 10.1016/s0015-0282(16)57848-0. Fertil Steril. 1995. PMID: 7672144 Free article.

5

Serum androgens and prostate cancer.

Nomura AM, Stemmermann GN, Chyou PH, Henderson BE, Stanczyk FZ. Nomura AM, et al. Among authors: stanczyk fz. Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):621-5. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8824364

6

5 alpha-reductase activity and prostate cancer: a case-control study using stored sera.

Guess HA, Friedman GD, Sadler MC, Stanczyk FZ, Vogelman JH, Imperato-McGinley J, Lobo RA, Orentreich N. Guess HA, et al. Among authors: stanczyk fz. Cancer Epidemiol Biomarkers Prev. 1997 Jan;6(1):21-4. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 8993793

7

A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase.

Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, Shi CY, Yu MC, Henderson BE, Reichardt JK. Makridakis N, et al. Among authors: stanczyk fz. Cancer Res. 1997 Mar 15;57(6):1020-2. Cancer Res. 1997. PMID: 9067262

8

Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.

Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E. Vatten LJ, et al. Among authors: stanczyk fz. Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):967-9. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9367072

9

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN, Henderson BE. Ross RK, et al. Among authors: stanczyk fz. Cancer Res. 1998 Oct 15;58(20):4497-504. Cancer Res. 1998. PMID: 9788589 Review.

10

Aromatase and breast cancer susceptibility.

Probst-Hensch NM, Ingles SA, Diep AT, Haile RW, Stanczyk FZ, Kolonel LN, Henderson BE. Probst-Hensch NM, et al. Among authors: stanczyk fz. Endocr Relat Cancer. 1999 Jun;6(2):165-73. doi: 10.1677/erc.0.0060165. Endocr Relat Cancer. 1999. PMID: 10731105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters